Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Coronary Artery Disease: HELP
Articles by Philippe Kolh
Based on 19 articles published since 2008
||||

Between 2008 and 2019, Philippe Kolh wrote the following 19 articles about Coronary Artery Disease.
 
+ Citations + Abstracts
1 Guideline 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS. 2018

Valgimigli, Marco / Bueno, Héctor / Byrne, Robert A / Collet, Jean-Philippe / Costa, Francesco / Jeppsson, Anders / Jüni, Peter / Kastrati, Adnan / Kolh, Philippe / Mauri, Laura / Montalescot, Gilles / Neumann, Franz-Josef / Petricevic, Mate / Roffi, Marco / Steg, Philippe Gabriel / Windecker, Stephan / Zamorano, Jose Luis / Levine, Glenn N / Anonymous3740973. · ·Eur J Cardiothorac Surg · Pubmed #29045581.

ABSTRACT: -- No abstract --

2 Guideline [2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS.] 2017

Valgimigli, Marco / Bueno, Héctor / Byrne, Robert A / Collet, Jean-Philippe / Costa, Francesco / Jeppsson, Anders / Jüni, Peter / Kastrati, Adnan / Kolh, Philippe / Mauri, Laura / Montalescot, Gilles / Neumann, Franz-Josef / Peticevic, Mate / Roffi, Marco / Steg, Philippe Gabriel / Windecker, Stephan / Zamorano, Jose Luis. ·Cardiology, Inselspital, Bern. marco.valgimigli@insel.ch. ·Kardiol Pol · Pubmed #29251754.

ABSTRACT: -- No abstract --

3 Guideline Perspectives on the 2014 ESC/EACTS Guidelines on Myocardial Revascularization : Fifty Years of Revascularization: Where Are We and Where Are We Heading? 2015

Costa, Francesco / Ariotti, Sara / Valgimigli, Marco / Kolh, Philippe / Windecker, Stephan / Anonymous4360830. ·Thoraxcenter, Erasmus Medical Center, 3015 CE, Rotterdam, The Netherlands. ·J Cardiovasc Transl Res · Pubmed #25986910.

ABSTRACT: The joint European Society of Cardiology and European Association of Cardio-Thoracic Surgery (ESC/EACTS) guidelines on myocardial revascularization collect and summarize the evidence regarding decision-making, diagnostics, and therapeutics in various clinical scenarios of coronary artery disease, including elective, urgent, and emergency settings. The 2014 document updates and extends the effort started in 2010, year of the first edition of these guidelines. Importantly, this latest edition provides a systematic review of all randomized clinical trials performed since 1980, comparing different strategies of myocardial revascularization, including coronary artery bypass graft (CABG), balloon angioplasty, percutaneous coronary intervention (PCI) with bare-metal stents (BMS) and first- and second-generation drug-eluting stents (DES). This review aims to highlight the most relevant novelties introduced by the 2014 edition of the ESC/EACTS myocardial revascularization guidelines as compared with the previous edition and to describe similarities and differences with the American societies' guidelines.

4 Guideline 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. 2013

Anonymous3190768 / Montalescot, Gilles / Sechtem, Udo / Achenbach, Stephan / Andreotti, Felicita / Arden, Chris / Budaj, Andrzej / Bugiardini, Raffaele / Crea, Filippo / Cuisset, Thomas / Di Mario, Carlo / Ferreira, J Rafael / Gersh, Bernard J / Gitt, Anselm K / Hulot, Jean-Sebastien / Marx, Nikolaus / Opie, Lionel H / Pfisterer, Matthias / Prescott, Eva / Ruschitzka, Frank / Sabaté, Manel / Senior, Roxy / Taggart, David Paul / van der Wall, Ernst E / Vrints, Christiaan J M / Anonymous3200768 / Zamorano, Jose Luis / Achenbach, Stephan / Baumgartner, Helmut / Bax, Jeroen J / Bueno, Héctor / Dean, Veronica / Deaton, Christi / Erol, Cetin / Fagard, Robert / Ferrari, Roberto / Hasdai, David / Hoes, Arno W / Kirchhof, Paulus / Knuuti, Juhani / Kolh, Philippe / Lancellotti, Patrizio / Linhart, Ales / Nihoyannopoulos, Petros / Piepoli, Massimo F / Ponikowski, Piotr / Sirnes, Per Anton / Tamargo, Juan Luis / Tendera, Michal / Torbicki, Adam / Wijns, William / Windecker, Stephan / Anonymous3210768 / Knuuti, Juhani / Valgimigli, Marco / Bueno, Héctor / Claeys, Marc J / Donner-Banzhoff, Norbert / Erol, Cetin / Frank, Herbert / Funck-Brentano, Christian / Gaemperli, Oliver / Gonzalez-Juanatey, José R / Hamilos, Michalis / Hasdai, David / Husted, Steen / James, Stefan K / Kervinen, Kari / Kolh, Philippe / Kristensen, Steen Dalby / Lancellotti, Patrizio / Maggioni, Aldo Pietro / Piepoli, Massimo F / Pries, Axel R / Romeo, Francesco / Rydén, Lars / Simoons, Maarten L / Sirnes, Per Anton / Steg, Ph Gabriel / Timmis, Adam / Wijns, William / Windecker, Stephan / Yildirir, Aylin / Zamorano, Jose Luis. ·The disclosure forms of the authors and reviewers are available on the ESC website www.escardio.org/guidelines. ·Eur Heart J · Pubmed #23996286.

ABSTRACT: -- No abstract --

5 Editorial Transatlantic Editorial: A Comparison Between European and North American Guidelines on Myocardial Revascularization. 2016

Kolh, Philippe / Kurlansky, Paul / Cremer, Jochen / Lawton, Jennifer / Siepe, Matthias / Fremes, Stephen. ·Cardiovascular Surgery Department, University Hospital (CHU, ULg) of Liège, Liège, Belgium. Electronic address: philippe.kolh@chu.ulg.ac.be. · Center for Innovation and Outcomes Research, Columbia University, New York, New York. · Cardiovascular Surgery Department, University Hospital Schleswig-Holstein, Kiel, Germany. · Division of Cardiothoracic Surgery, Washington University School of Medicine, St. Louis, Missouri. · Department of Cardiovascular Surgery, University Heart Centre Freiburg Bad Krozingen, Bad Krozingen, Germany. · Division of Cardiac Surgery, Schulich Heart Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada. ·Ann Thorac Surg · Pubmed #27139371.

ABSTRACT: -- No abstract --

6 Editorial Transatlantic Editorial: a comparison between European and North American guidelines on myocardial revascularization. 2016

Kolh, Philippe / Kurlansky, Paul / Cremer, Jochen / Lawton, Jennifer / Siepe, Matthias / Fremes, Stephen. ·Cardiovascular Surgery Department, University Hospital (CHU, ULg) of Liège, Liège, Belgium philippe.kolh@chu.ulg.ac.be. · Center for Innovation and Outcomes Research, Columbia University, New York, NY, USA. · Cardiovascular Surgery Department, University Hospital Schleswig-Holstein, Kiel, Germany. · Division of Cardiothoracic Surgery, Washington University School of Medicine, St. Louis, MO, USA. · Department of Cardiovascular Surgery, University Heart Centre Freiburg Bad Krozingen, Bad Krozingen, Germany. · Division of Cardiac Surgery, Schulich Heart Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada. ·Eur J Cardiothorac Surg · Pubmed #27130949.

ABSTRACT: -- No abstract --

7 Editorial Doing better in more complex patients: leading the way for QUIP. 2016

Osnabrugge, Ruben L / Kappetein, A Pieter / Head, Stuart J / Kolh, Philippe. ·Erasmus University Medical Center, Rotterdam, Netherlands. · Department of Cardiovascular Surgery, University Hospital (CHU, ULg) of Liège, Liège, Belgium philippe.kolh@chu.ulg.ac.be. ·Eur J Cardiothorac Surg · Pubmed #26242898.

ABSTRACT: -- No abstract --

8 Editorial Structure and functioning of the Heart Team: primum non nocere. 2015

Stefanini, Giulio G / Kolh, Philippe. ·Cardiovascular Department, Humanitas Research Hospital, Rozzano, Milan, Italy. · Department of Cardiovascular Surgery, University Hospital (CHU, ULg) of Liège, Liège, Belgium philippe.kolh@chu.ulg.ac.be. ·Eur J Cardiothorac Surg · Pubmed #26242899.

ABSTRACT: -- No abstract --

9 Editorial Bilateral internal thoracic artery grafts for myocardial revascularization in insulin-dependent diabetic patients: time for wide clinical practice? 2015

Jatene, Fabio Biscegli / Kolh, Philippe. ·Cirurgia Cardiovascular, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil. · Department of Cardiovascular Surgery, University Hospital (CHU, ULg) of Liège, Liège, Belgium philippe.kolh@chu.ulg.ac.be. ·Eur J Cardiothorac Surg · Pubmed #25501320.

ABSTRACT: -- No abstract --

10 Editorial Surgical or percutaneous revascularization for isolated left anterior descending stenoses: are we in the same boat? 2015

Stefanini, Giulio G / Windecker, Stephan / Kolh, Philippe. ·Department of Cardiology, Bern University Hospital, Bern, Switzerland. · Department of Cardiovascular Surgery, University Hospital (CHU, ULg) of Liège, Sart Tilman, Liège, Belgium philippe.kolh@chu.ulg.ac.be. ·Eur J Cardiothorac Surg · Pubmed #25312531.

ABSTRACT: -- No abstract --

11 Editorial Analysis of on-pump and off-pump surgery in the Arterial Revascularization Trial. 2015

Poullis, Michael / Kolh, Philippe. ·Liverpool Heart and Chest Hospital, Liverpool, UK mpoullis@hotmail.com. · Department of Cardiovascular Surgery, University Hospital of Liege, CHU Sart Tilman, Liege, Belgium. ·Eur J Cardiothorac Surg · Pubmed #25217502.

ABSTRACT: -- No abstract --

12 Review Impact of preoperative use of P2Y12 receptor inhibitors on clinical outcomes in cardiac and non-cardiac surgery: A systematic review and meta-analysis. 2017

Siller-Matula, Jolanta M / Petre, Alexandra / Delle-Karth, Georg / Huber, Kurt / Ay, Cihan / Lordkipanidzé, Marie / De Caterina, Raffaele / Kolh, Philippe / Mahla, Elisabeth / Gersh, Bernard J. ·1 Department of Cardiology, Medical University of Vienna, Austria. · 2 3rd Medical Department of Cardiology and Emergency Medicine, Wilhelminen Hospital, Vienna, Austria. · 3 Division of Haematology and Haemostaseology, Department of Medicine I, Medical University of Vienna, Austria. · 4 Faculty of Pharmacy, University of Montreal; Research Center, Montreal Heart Institute, Canada. · 5 Institute of Cardiology, 'G d'Annunzio' University - Chieti-Pescara, Chieti, Italy. · 6 Department of Cardiothoracic Surgery, University Hospital of Liege, Belgium. · 7 Department of Anaesthesiology and Intensive Care Medicine, Medical University of Graz, Austria. · 8 Division of Cardiovascular Diseases, Department of Internal Medicine, Mayo Clinic, College of Medicine Rochester, USA. ·Eur Heart J Acute Cardiovasc Care · Pubmed #25943554.

ABSTRACT: OBJECTIVE: To review systematically the evidence and perform a meta-analysis of benefits and risks associated with use of P2Y RESULTS: Fifty-four studies met the selection criteria and included 50,048 patients. Preoperative use of clopidogrel on top of aspirin in patients undergoing coronary artery bypass graft was associated with a 2.5-fold increased risk of re-operation for bleeding (95% CI: 1.92-3.25; p<0.001) and a 1.47-fold increased risk of death (95% CI: 1.25-1.72; p<0.001), but did not diminish the risk for myocardial infarction (RR: 0.96; 95% CI: 0.75-1.25; p=0.18) or MACE (RR: 1.16; 95% CI: 0.90--1.50; p=0.30). In patients undergoing non-cardiac surgery, preoperative use of clopidogrel increased the RR of re-operation for major bleeding by 2.05-fold (95% CI: 1.13-3.73; p=0.002) but did not reduce the RR for MACE or death. Clopidogrel use during cardiac device implantation raised the RR for procedure-related haematoma by 3.0-fold (95% CI: 1.30--6.94; p=0.001). Whereas preoperative ticagrelor use did not increase the risk for mortality (RR: 1.03; 95% CI: 0.49-2.14), preoperative prasugrel use tended to increase the risk for death (RR: 5.06; 95% CI: 0.54-47.65). CONCLUSION: Preoperative exposure to clopidogrel on top of aspirin did not reduce the risk of MACE but was associated with increased risk of bleeding and mortality.

13 Article Geographical differences in the ratio of percutaneous and surgical myocardial revascularization procedures in the treatment of coronary artery disease. 2017

Piccolo, Raffaele / Windecker, Stephan / Kolh, Philippe. ·Department of Cardiology, Bern University Hospital, Inselspital, Bern, Switzerland. · Department of Cardiovascular Surgery, University Hospital (CHU, ULg) of Liège, CHU Sart Tilman, Liège, Belgium. ·Eur J Cardiothorac Surg · Pubmed #28874028.

ABSTRACT: -- No abstract --

14 Article Percutaneous coronary interventions with second-generation drug-eluting stent versus off-pump coronary artery bypass grafting: mid-term results. 2017

Berdajs, Denis / Kolh, Philippe. ·Division of Cardiac Surgery, University Hospital Basel, Basel, Switzerland. · Department of Cardiovascular Surgery, University Hospital (CHU, ULg) of Liège, CHU Sart Tilman, Liège, Belgium. ·Eur J Cardiothorac Surg · Pubmed #28874026.

ABSTRACT: -- No abstract --

15 Article Myocardial revascularization in patients with left main or multivessel coronary artery disease at high surgical risk: conventional wisdom versus risk prediction model. 2017

Piccolo, Raffaele / Windecker, Stephan / Kolh, Philippe. ·Department of Cardiology, Bern University Hospital-Inselspital, Bern, Switzerland. · Department of Cardiovascular Surgery, University Hospital (CHU, ULg) of Liege, CHU Sart Tilman, Liège, Belgium. ·Eur J Cardiothorac Surg · Pubmed #28329202.

ABSTRACT: -- No abstract --

16 Article Revascularisation versus medical treatment in patients with stable coronary artery disease: network meta-analysis. 2014

Windecker, Stephan / Stortecky, Stefan / Stefanini, Giulio G / da Costa, Bruno R / Rutjes, Anne Wilhelmina / Di Nisio, Marcello / Silletta, Maria G / Maione, Ausilia / Alfonso, Fernando / Clemmensen, Peter M / Collet, Jean-Philippe / Cremer, Jochen / Falk, Volkmar / Filippatos, Gerasimos / Hamm, Christian / Head, Stuart / Kappetein, Arie Pieter / Kastrati, Adnan / Knuuti, Juhani / Landmesser, Ulf / Laufer, Günther / Neumann, Franz-Joseph / Richter, Dimitri / Schauerte, Patrick / Sousa Uva, Miguel / Taggart, David P / Torracca, Lucia / Valgimigli, Marco / Wijns, William / Witkowski, Adam / Kolh, Philippe / Jüni, Peter. · ·BMJ · Pubmed #24958153.

ABSTRACT: OBJECTIVE: To investigate whether revascularisation improves prognosis compared with medical treatment among patients with stable coronary artery disease. DESIGN: Bayesian network meta-analyses to combine direct within trial comparisons between treatments with indirect evidence from other trials while maintaining randomisation. ELIGIBILITY CRITERIA FOR SELECTING STUDIES: A strategy of initial medical treatment compared with revascularisation by coronary artery bypass grafting or Food and Drug Administration approved techniques for percutaneous revascularization: balloon angioplasty, bare metal stent, early generation paclitaxel eluting stent, sirolimus eluting stent, and zotarolimus eluting (Endeavor) stent, and new generation everolimus eluting stent, and zotarolimus eluting (Resolute) stent among patients with stable coronary artery disease. DATA SOURCES: Medline and Embase from 1980 to 2013 for randomised trials comparing medical treatment with revascularisation. MAIN OUTCOME MEASURE: All cause mortality. RESULTS: 100 trials in 93,553 patients with 262,090 patient years of follow-up were included. Coronary artery bypass grafting was associated with a survival benefit (rate ratio 0.80, 95% credibility interval 0.70 to 0.91) compared with medical treatment. New generation drug eluting stents (everolimus: 0.75, 0.59 to 0.96; zotarolimus (Resolute): 0.65, 0.42 to 1.00) but not balloon angioplasty (0.85, 0.68 to 1.04), bare metal stents (0.92, 0.79 to 1.05), or early generation drug eluting stents (paclitaxel: 0.92, 0.75 to 1.12; sirolimus: 0.91, 0.75 to 1.10; zotarolimus (Endeavor): 0.88, 0.69 to 1.10) were associated with improved survival compared with medical treatment. Coronary artery bypass grafting reduced the risk of myocardial infarction compared with medical treatment (0.79, 0.63 to 0.99), and everolimus eluting stents showed a trend towards a reduced risk of myocardial infarction (0.75, 0.55 to 1.01). The risk of subsequent revascularisation was noticeably reduced by coronary artery bypass grafting (0.16, 0.13 to 0.20) followed by new generation drug eluting stents (zotarolimus (Resolute): 0.26, 0.17 to 0.40; everolimus: 0.27, 0.21 to 0.35), early generation drug eluting stents (zotarolimus (Endeavor): 0.37, 0.28 to 0.50; sirolimus: 0.29, 0.24 to 0.36; paclitaxel: 0.44, 0.35 to 0.54), and bare metal stents (0.69, 0.59 to 0.81) compared with medical treatment. CONCLUSION: Among patients with stable coronary artery disease, coronary artery bypass grafting reduces the risk of death, myocardial infarction, and subsequent revascularisation compared with medical treatment. All stent based coronary revascularisation technologies reduce the need for revascularisation to a variable degree. Our results provide evidence for improved survival with new generation drug eluting stents but no other percutaneous revascularisation technology compared with medical treatment.

17 Article Invited commentary. 2013

Kolh, Philippe. ·CT Surgery, University Hospital of Liege, CHU Sart Tilman B35, Liege 4000, Belgium. philippe.kolh@chu.ulg.ac.be ·Ann Thorac Surg · Pubmed #23910103.

ABSTRACT: -- No abstract --

18 Article Appropriate myocardial revascularization: a joint viewpoint from an interventional cardiologist and a cardiac surgeon. 2009

Wijns, William / Kolh, Philippe. ·Cardiovascular Center Aalst, Moorselbaan, 164, 9300 Aalst, Belgium. william.wijns@olvz-aalst.be ·Eur Heart J · Pubmed #19684022.

ABSTRACT: -- No abstract --

19 Minor ESC/EACTS myocardial revascularization guidelines 2014. 2014

Kolh, Philippe / Windecker, Stephan. · ·Eur Heart J · Pubmed #25482397.

ABSTRACT: -- No abstract --